| P50 | author | Teun Bousema | Q44168464 |
| | Marga van de Vegte-Bolmer | Q45380602 |
| | Morten Hanefeld Dziegiel | Q55100179 |
| | Susheel K. Singh | Q55182102 |
| | Michael Theisen | Q58310143 |
| | Robert Sauerwein | Q72530989 |
| | Will Roeffen | Q72536015 |
| P2093 | author name string | Michael Christiansen | |
| | Theo Arens | |
| | Theisen, M. | |
| | Sophie Jones | |
| | Bright Adu | |
| | Adu, B. | |
| | Singh, S.K. | |
| | Christiansen, M. | |
| | Dziegiel, M.H. | |
| | Bousema, T. | |
| | Jones, S. | |
| | Roeffen, W. | |
| | Sauerwein, R. | |
| | Amoah, L. | |
| | Andersen, G. | |
| | Arens, T. | |
| | Gorm Andersen | |
| | Linda Amoah | |
| | Régis Wendpayangde Tiendrebeogo | |
| | van de Vegte-Bolmer, M. | |
| P2860 | cites work | The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania | Q28744581 |
| | Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing | Q30897109 |
| | A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies | Q33198902 |
| | What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines | Q33368617 |
| | A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 |
| | The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections | Q33587496 |
| | A Research Agenda to Underpin Malaria Eradication | Q33818020 |
| | Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity | Q34008755 |
| | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination | Q34177472 |
| | Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus | Q34533068 |
| | Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission | Q35598030 |
| | Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich pro | Q36227049 |
| | Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito | Q36351262 |
| | Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 |
| | Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets? | Q37487002 |
| | Lactococcus lactis-based vaccines from laboratory bench to human use: an overview | Q37966471 |
| | Evidence of non-neutral polymorphism in Plasmodium falciparum gamete surface protein genes Pfs47 and Pfs48/45. | Q38876779 |
| | Transmission-blocking effects of sera from malaria-exposed individuals on Plasmodium falciparum isolates from gametocyte carriers | Q38977787 |
| | Uses of mosquito-stage transmission-blocking vaccines against Plasmodium falciparum | Q39473663 |
| | Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal | Q39515540 |
| | The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro | Q39569469 |
| | Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera | Q40959724 |
| | Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells | Q41003251 |
| | Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes | Q41946006 |
| | Studies on antigenic competition | Q42101792 |
| | Flow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition | Q42275109 |
| | Measuring the blockade of malaria transmission--an analysis of the Standard Membrane Feeding Assay | Q43571629 |
| | Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii | Q43645737 |
| | A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults | Q43945792 |
| | Transmission blocking malaria vaccines | Q44145217 |
| | Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures | Q44166470 |
| | A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule-specific competition enzyme-linked immunosorbent assay. | Q44169960 |
| | The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas | Q44238175 |
| | Naturally acquired antibodies to the glutamate-rich protein are associated with protection against plasmodium falciparum malaria | Q46163143 |
| | Conservation and heterogeneity of the glutamate-rich protein (GLURP) among field isolates and laboratory lines of Plasmodium falciparum | Q47812641 |
| | Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. | Q47829675 |
| | Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. | Q47837358 |
| | Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast | Q47857505 |
| | Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F. | Q48007592 |
| | Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial | Q48034345 |
| | Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum | Q48103837 |
| | Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen | Q73509627 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| | malaria vaccine | Q6741353 |
| | P48/45 | Q18971545 |
| | malaria transmission | Q56928847 |
| P304 | page(s) | 2623-2630 | |
| P577 | publication date | 2014-01-01 | |
| | 2014-03-21 | |
| P1433 | published in | Elsevier BV | Q746413 |
| | Vaccine | Q7907941 |
| P1476 | title | A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages | |
| P478 | volume | 32 | |